Literature DB >> 19223866

Long-term transgene expression in the central nervous system using DNA nanoparticles.

David M Yurek1, Anita M Fletcher, George M Smith, Kim B Seroogy, Assem G Ziady, Joseph Molter, Tomasz H Kowalczyk, Linas Padegimas, Mark J Cooper.   

Abstract

This study demonstrates proof of concept for delivery and expression of compacted plasmid DNA in the central nervous system. Plasmid DNA was compacted with polyethylene glycol substituted lysine 30-mer peptides, forming rod-like nanoparticles with diameters between 8 and 11 nm. Here we show that an intracerebral injection of compacted DNA can transfect both neurons and glia, and can produce transgene expression in the striatum for up to 8 weeks, which was at least 100-fold greater than intracerebral injections of naked DNA plasmids. Bioluminescent imaging (BLI) of injected animals at the 11th postinjection week revealed significantly higher transgene activity in animals receiving compacted DNA plasmids when compared to animals receiving naked DNA. There was minimal evidence of brain inflammation. Intrastriatal injections of a compacted plasmid encoding for glial cell line-derived neurotrophic factor (pGDNF) resulted in a significant overexpression of GDNF protein in the striatum 1-3 weeks after injection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19223866      PMCID: PMC2835115          DOI: 10.1038/mt.2009.2

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  35 in total

1.  Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease.

Authors:  J H Kordower; M E Emborg; J Bloch; S Y Ma; Y Chu; L Leventhal; J McBride; E Y Chen; S Palfi; B Z Roitberg; W D Brown; J E Holden; R Pyzalski; M D Taylor; P Carvey; Z Ling; D Trono; P Hantraye; N Déglon; P Aebischer
Journal:  Science       Date:  2000-10-27       Impact factor: 47.728

2.  Neuron-specific expression of therapeutic proteins: evaluation of different cellular promoters in recombinant adenoviral vectors.

Authors:  S Kügler; L Meyn; H Holzmüller; E Gerhardt; S Isenmann; J B Schulz; M Bähr
Journal:  Mol Cell Neurosci       Date:  2001-01       Impact factor: 4.314

3.  Recombinant adeno-associated viral vector-mediated glial cell line-derived neurotrophic factor gene transfer protects nigral dopamine neurons after onset of progressive degeneration in a rat model of Parkinson's disease.

Authors:  R J Mandel; R O Snyder; S E Leff
Journal:  Exp Neurol       Date:  1999-11       Impact factor: 5.330

4.  Cell surface nucleolin serves as receptor for DNA nanoparticles composed of pegylated polylysine and DNA.

Authors:  Xuguang Chen; Dianne M Kube; Mark J Cooper; Pamela B Davis
Journal:  Mol Ther       Date:  2007-12-04       Impact factor: 11.454

5.  Plasmid size up to 20 kbp does not limit effective in vivo lung gene transfer using compacted DNA nanoparticles.

Authors:  T L Fink; P J Klepcyk; S M Oette; C R Gedeon; S L Hyatt; T H Kowalczyk; R C Moen; M J Cooper
Journal:  Gene Ther       Date:  2006-03-09       Impact factor: 5.250

6.  Aspartoacylase gene transfer to the mammalian central nervous system with therapeutic implications for Canavan disease.

Authors:  P Leone; C G Janson; L Bilaniuk; Z Wang; F Sorgi; L Huang; R Matalon; R Kaul; Z Zeng; A Freese; S W McPhee; E Mee; M J During; L Bilianuk
Journal:  Ann Neurol       Date:  2000-07       Impact factor: 10.422

7.  Noninvasive gene targeting to the brain.

Authors:  N Shi; W M Pardridge
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

8.  Long-term rAAV-mediated gene transfer of GDNF in the rat Parkinson's model: intrastriatal but not intranigral transduction promotes functional regeneration in the lesioned nigrostriatal system.

Authors:  D Kirik; C Rosenblad; A Bjorklund; R J Mandel
Journal:  J Neurosci       Date:  2000-06-15       Impact factor: 6.167

9.  Increased persistence of lung gene expression using plasmids containing the ubiquitin C or elongation factor 1alpha promoter.

Authors:  D R Gill; S E Smyth; C A Goddard; I A Pringle; C F Higgins; W H Colledge; S C Hyde
Journal:  Gene Ther       Date:  2001-10       Impact factor: 5.250

10.  Efficacy of nonviral gene transfer in the canine brain.

Authors:  Seunguk Oh; G Elizabeth Pluhar; Elizabeth A McNeil; Kurt M Kroeger; Chunyan Liu; Maria G Castro; Pedro R Lowenstein; Andrew Freese; John R Ohlfest
Journal:  J Neurosurg       Date:  2007-07       Impact factor: 5.115

View more
  36 in total

Review 1.  Nanoparticles for retinal gene therapy.

Authors:  Shannon M Conley; Muna I Naash
Journal:  Prog Retin Eye Res       Date:  2010-05-07       Impact factor: 21.198

2.  Non-degradative intracellular trafficking of highly compacted polymeric DNA nanoparticles.

Authors:  Anthony J Kim; Nicholas J Boylan; Jung Soo Suk; Samuel K Lai; Justin Hanes
Journal:  J Control Release       Date:  2011-10-30       Impact factor: 9.776

3.  Reducible DNA nanoparticles enhance in vitro gene transfer via an extracellular mechanism.

Authors:  Wenchao Sun; Pamela B Davis
Journal:  J Control Release       Date:  2010-05-12       Impact factor: 9.776

4.  Transgene expression in the striatum following intracerebral injections of DNA nanoparticles encoding for human glial cell line-derived neurotrophic factor.

Authors:  A M Fletcher; T H Kowalczyk; L Padegimas; M J Cooper; D M Yurek
Journal:  Neuroscience       Date:  2011-08-04       Impact factor: 3.590

5.  Optimization of hCFTR lung expression in mice using DNA nanoparticles.

Authors:  Linas Padegimas; Tomasz H Kowalczyk; Sam Adams; Chris R Gedeon; Sharon M Oette; Karla Dines; Susannah L Hyatt; Ozge Sesenoglu-Laird; Olena Tyr; Robert C Moen; Mark J Cooper
Journal:  Mol Ther       Date:  2011-09-27       Impact factor: 11.454

Review 6.  Current Neurogenic and Neuroprotective Strategies to Prevent and Treat Neurodegenerative and Neuropsychiatric Disorders.

Authors:  I M Carvalho; P B Coelho; P C Costa; C S Marques; R S Oliveira; D C Ferreira
Journal:  Neuromolecular Med       Date:  2015-09-15       Impact factor: 3.843

7.  Novel Focused Ultrasound Gene Therapy Approach Noninvasively Restores Dopaminergic Neuron Function in a Rat Parkinson's Disease Model.

Authors:  Brian P Mead; Namho Kim; G Wilson Miller; David Hodges; Panagiotis Mastorakos; Alexander L Klibanov; James W Mandell; Jay Hirsh; Jung Soo Suk; Justin Hanes; Richard J Price
Journal:  Nano Lett       Date:  2017-05-18       Impact factor: 11.189

8.  DNA nanoparticle-mediated thymulin gene therapy prevents airway remodeling in experimental allergic asthma.

Authors:  Adriana L da Silva; Sabrina V Martini; Soraia C Abreu; Cynthia dos S Samary; Bruno L Diaz; Sandra Fernezlian; Vanessa Karen de Sá; Vera Luiza Capelozzi; Nicholas J Boylan; Rodolfo Gustavo Goya; Jung Soo Suk; Patricia R M Rocco; Justin Hanes; Marcelo M Morales
Journal:  J Control Release       Date:  2014-02-17       Impact factor: 9.776

9.  Long distance directional growth of dopaminergic axons along pathways of netrin-1 and GDNF.

Authors:  C Zhang; Y Jin; K S Ziemba; A M Fletcher; B Ghosh; E Truit; D M Yurek; G M Smith
Journal:  Exp Neurol       Date:  2013-10-04       Impact factor: 5.330

10.  Targeted nonviral delivery vehicles to neural progenitor cells in the mouse subventricular zone.

Authors:  Ester J Kwon; Jurate Lasiene; Berit E Jacobson; In-Kyu Park; Philip J Horner; Suzie H Pun
Journal:  Biomaterials       Date:  2009-12-09       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.